2012 CABA Annual Conference: Meeting the Challenges Through Innovation
展望生物医药行业前景:以创新迎接挑战
Date: Saturday, April 7, 2012; 8:30 AM - 9:00 PM
Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA
Speakers and panelists include senior executives of US and Chinese bio/pharmaceutical companies, entrepreneurs, physicians, professors, and government officials
Themes/Topics
• Industry Trends and Key Technology Innovations
• Globalized R&D: Resourcing and Collaborations
• Career Development & Entrepreneurship
• Networking Receptions & Vendor Exhibitions
Confirmed Speakers
* Mark Bunnage, Ph.D., Pfizer - VP, Head of Chem. Bio. Research
* Chiang Li, M.D. Boston Biomedical – Founder and CEO
* Detlev Biniszkiewicz, Ph.D., AstraZenaca - VP, IMED Strategy for Oncology
* Michael Foley, Ph.D., The Broad Institute - Director of Chemical biology
* Mark Namchuk, Ph.D., Vertex Pharmaceuticals - SVP, Research
* Daniel Bollag, Ph.D., ARIAD Pharmaceuticals - SVP, Regulatory Affairs and Quality
* Ron Renaud, Idenix Pharmaceuticals - CEO
* Markus Warmuth, M.D., H3 Biomedicine - CEO
* Steve Hale, Ph.D., Ensemble Therapeutics - VP, Screening & Biochem
* Frank Feist, Ph.D., NobelGen - CEO
* Chen Chen, Ph.D., Sundia - CEO
* George Shi, Ph.D., Anichem - CSO
* Jifeng Liu, Ph.D., Aberiona - President
* Joshua Zhang, M.D./Ph.D., ARIAD - Sr. Medical Director
* Hui Li, Ph.D., BioDuro/PPD, - Head of Business Development
* Boliang Lou, Ph.D. Pharmaron - Chairman and CEO
and more......
